Organic Active Ingredients TRIZ Cases

See how electrospinning and ultrasonic spray pyrolysis produce azithromycin-coated nanofibers f

See how polyurethane or latex foam infused with cannabidiol oil enables controlled vapor and sk

See how a modified cellulose coating inside a drinking straw progressively releases sweeteners,

A methylene blue and phosphoric acid composition controls wound infection while promoting closure, bone formation, and lower post-operative pain.

See how segmented filling chambers with cannabinoid-containing regions deliver calming effects

See how a bilayer berberine nanofiber and mineralized collagen membrane improves bioavailabilit

See how a triple-acid preservative system with pH buffering inhibits microbial growth in high-w

See how a flocked fibrous patch adheres to mucosal surfaces without sutures, enabling drug deli

See how covalently linked nanofiber-hydrogel composites resolve the contradiction between mecha

A buffered benzoic-succinic-phytic acid lotion keeps high-water cellulosic wet wipes gentle on skin while maintaining microbial inhibition.

See how hydroxyacetophenone as the sole preservative in wet wipe impregnation prevents microbia

See how electrospun nanofibers covalently linked to hydrogel moieties balance mechanical streng

See how a nicotine pouch matrix composition combines ion exchange resin and water-soluble carri

See how a water-free triglyceride-nicotine liquid mixture in a hydrophobic pouch enhances flavo

See how a water-soluble matrix with ion exchange resin delivers stable nicotine through oral mu

See how aliphatic polyester binders enable heat sealing and biodegradability in water-permeable

A rotor-stator sensor harvests energy from low-speed duct airflow to measure fluid conditions and simplify HVAC control installation.

See how a fibrous chitosan salt composition with controlled molecular weight and deacetylation

See how hyaluronic acid wound dressing delivers localized antibiotics to reduce postoperative i

See how chemically bonded phosphate groups on synthetic and cellulose fibers reduce skin irrita

See how liquefied inert gas and sublimating dry-ice media replace conventional beads to elimina

See how controlled chitosan molecular weight and deacetylation enable a haemostat to degrade fu

See how a chitosan-based fibrous haemostat with physiologically acceptable acid degrades within

See how core-sheath electrospinning with aqueous excipients maintains protein activity during s

See how novel pyridoquinazoline derivatives achieve selective TYK2 and JAK3 inhibition through

See how novel pyridoquinazoline derivatives achieve selective TYK2, JAK3, and ARK5 inhibition t

See how spatially-separated conductive protrusions freeze small skin regions to produce gradual

See how spatially-separated conductive protrusions freeze small skin regions to produce gradual

See how bismuth-ion passivation protects silver layers without copper, enabling lead-free paint

See how spatially-separated cryogenic protrusions freeze small skin regions to inhibit melanin

Small cooled protrusions freeze separated skin spots to lighten hyperpigmented areas gradually without visible depigmented patches.

A metering unit mixes hyaluronic acid into potable water for shower or oral use, avoiding greasy creams while improving skin absorption.

Acoustic cavitation treats sliver fibers in parallel, attaching insoluble flame-retardant or antimicrobial compounds evenly without bundling or leaching.

A multilayer tear-resistant lidding keeps pharmaceutical actives stable against humidity and oxygen while remaining penetrable in brewing machines.

Pre-formulated solubilisate capsules improve bioavailability of poorly water-soluble actives while simplifying beverage preparation and dissolution.

Crosslinked stellate prepolymer coatings simplify hydrogel surface treatment while reducing water residue, soiling, and protein adhesion.

Carbazole compounds induce tumor cell death and modulate NF-κB activity, helping strengthen chemotherapy and radiation treatment efficacy.

Segmented dispenser ports improve cryogranulation of viscous pharmaceutical slurries by reducing clogging, streaming, and pellet agglomeration.

Novel TRPM8 modulators extend skin and mucosa cooling while reducing irritation, odor, volatility, and solubility limits.

A quick-break aerosol foam improves corticosteroid skin delivery while reducing irritation, rubbing, and application waste.

A quick-break aerosol foam improves corticosteroid skin penetration while reducing irritation and making topical application easier.

Axially spaced functional channels spread gas evenly through granular beds, improving drying uniformity across changing fill levels.

Water-soluble dinuclear metal complexes bind phosphate esters for MALDI-TOF detection, dye displacement assays, and phosphoprotein separation.

A metering device mixes hyaluronic acid into potable water for showering or drinking, improving skin absorption without greasy residues.

Pressure-triggered motor agitation turns liquid into stable foam for gradual inhalation, avoiding smoke and vapor delivery drawbacks.

Mechanical agitation turns nicotine liquid into stable foam, enabling longer inhalation without burning or vaporizing.

Core-shell nanocomposites combine targeting antibodies, drug release, and Raman signatures to detect cancer cells while improving delivery specificity.

Self-assembling bioresorbable electrodes form in situ for precise tissue integration, avoiding invasive implantation and removal surgery.

Protonating nicotine before encapsulation preserves nicotine delivery while flavors are selectively encapsulated to improve vaping acceptability and reduce toxicants.

Silver-decorated gold nanorods combine targeting antibodies, drug release, and strong Raman signals to confirm delivery to cancer cells.

Cold atmospheric plasma pre-sensitizes cancer cells so lower-dose reactive treatment can improve killing selectivity while limiting harm to healthy cells.

Cyclodextrin encapsulation in a water-based aerosol formulation stabilizes flavor and nicotine delivery while reducing glycerol- and glycol-linked toxicants.

Glutarate compounds such as α-ketoglutarate protect tissue during ischemia-reperfusion by limiting infarct size and improving heart recovery.

External magnetic fields trigger magnetoelectric silica nanoparticles to release doxorubicin at tumors, reducing systemic toxicity.

Mass spectrometry with ion selection and fragmentation improves teriflunomide quantitation accuracy in plasma and serum samples.

Capacitive liquid sensing triggers automatic pod refilling only when reservoir level drops, reducing messy user handling in vaping systems.

A 3D-printed union body integrates sealing and grounding features to cut cable gland parts, post-processing, size, and maintenance.

Synthetic RNA with non-canonical nucleotides improves cell transfection and reprogramming while avoiding exogenous DNA, toxicity, and mutation risk.

Capacitance sensing detects low liquid in a reusable vaping pod and triggers automatic refilling to keep operation simple and reduce waste.

Primary-amine derivatization stabilizes beta-lactam calibrators and internal standards against hydrolysis for more reliable LC-MS/MS drug monitoring.

Agave syrup replaces artificial excipients to mask bitter drug taste while keeping oral suspensions stable and easy to drink.

Glycine-conjugated bile acids provide an objective way to detect mood disorder status and track probiotic treatment response.

Combining PD-1 and PARP inhibitors improves outcomes in platinum-resistant and BRCA-negative cancers while lowering monotherapy toxicity.

A copper speciation assay replaces inaccurate EDTA ultracentrifugation to measure serum NCC precisely and simplify Wilson's Disease monitoring.

An asymmetric composite free layer in perpendicular shape anisotropy MTJs lowers switching current while preserving thermal stability.

Reduced free-layer exchange energy in a perpendicular MTJ lowers switching current while preserving thermal stability in STT-MRAM.

Low-energy light paired with collagen-rich bioactive compositions speeds wound closure and tissue regeneration while limiting thermal damage and pain.

A saddle seat, sliding rail, and four-point harness let medical attendants lean forward securely while reducing seat bulk and weight.

Novel compounds selectively disrupt YAP/TEAD binding to suppress target gene expression and tumor growth in Hippo pathway-driven disease.

Natural agave syrup masks bitter drug taste while keeping oral suspensions stable, pourable, and suitable for accurate pediatric dosing.

Cyclodextrin flavor encapsulation in a water-based aerosol improves flavor release consistency while reducing toxicant components.

Tandem mass spectrometry tracks teriflunomide in plasma with higher sensitivity and specificity for drug elimination monitoring.

A polymer-based amorphous solid dispersion improves the solubility and oral bioavailability of influenza endonuclease inhibitors.

Thiazolides block influenza HA maturation to impair viral trafficking and replication, offering a new option against resistant and emerging strains.

A graphite nanomaterial MALDI-MS matrix cuts low-mass background noise for rapid, accurate screening of brain-penetrant antitumor compounds.

Synthetic RNA with non-canonical nucleotides and treated albumin improves cell transfection and gene editing while lowering toxicity and mutation risk.

Synthetic RNA and ion-exchange-treated albumin improve cell transfection and reprogramming while reducing toxicity and mutation risk.

RNA gene panels and a machine-learning classifier identify tumor microenvironments to match patients with more suitable cancer therapies.

A replaceable fluid circuit and concentration feedback control enable precise medicament mixing without large home water purification plants.

Automatic UAV dispatch sends live scene data from hard-to-reach emergencies, speeding resource assessment and response decisions.

Automated UAV dispatch sends medical payloads and live visual data to remote emergency scenes, improving resource selection and response speed.

A compact home fluid-prep setup uses purified water, disposable circuits, and concentration feedback to deliver precise medicament mixing safely.

Brain-penetrant 2,3-dihydrofuro[2,3-b]pyridine compounds inhibit OGA to limit tau hyperphosphorylation and aggregation in Alzheimer's disease.

A porous ceramic carrier preloads active drug doses for controlled vapor release, avoiding liquid reservoirs, leakage, and misuse.

Tagged replaceable modules combine on-demand water purification and precise medicament mixing for safe home or critical care use.

A nitrogen-doped titanium oxide layer, femtosecond laser texturing, and electrospinning improve tacrolimus binding and delayed elution without polymers.

A porous solid carrier stores active agents in its pores for heated vapor delivery, avoiding liquid leaks, harmful additives, and poor dose control.

Alternating high- and low-amplitude TTFields disrupt mitosis, reduce cancer cell motility, and limit skin heating during treatment.

Modified clay particles and nonionic triblock copolymers improve oral care antimicrobial dispersion, stability, and biofilm control.

Combining liposomal eribulin with PD-1 antagonists boosts antitumor activity and helps address resistance seen with single-drug therapy.

Selective EP4 antagonist compounds block PGE2 signaling to curb tumor immunosuppression, metastasis, and inflammatory disease.

rAAV delivery of anti-VEGF genes enables sustained ocular therapy for AMD, reducing repeated injections and related inflammation and compliance issues.

A selective dihydronaphthyridinone RIPK1 inhibitor blocks RIP1-dependent necrosis to reduce inflammation and cell death with low toxicity.

A peripheral MT1-preferring benzimidazole agonist improves insulin resistance, weight gain, and liver triglycerides in obesity and NAFLD.

A dispersible alpelisib tablet balances high drug loading with rapid aqueous dispersion, improving administration for patients with swallowing difficulties.

Porous hyaluronic acid microneedles use disulfide-linked degradation to deliver biologics while sampling interstitial fluid for theranostic use.

Combining pimozide with methotrexate improves rheumatoid arthritis treatment efficacy while helping reduce side effects versus single-agent therapy.

Tricyclic sulfone compounds modulate RORγ to inhibit IL-17 production, supporting treatment of autoimmune and inflammatory disorders.

Muco-adhesive and enteric-coated levodopa particles extend intestinal absorption to smooth plasma fluctuations and prolong Parkinson's symptom control.

Maleic acid in pressurized MDI formulations limits β2-agonist degradation in co-solvent systems and preserves shelf-life stability.

Selective fast-fiber myosin inhibition reduces muscle breakdown while preserving strength and mobility in Duchenne and related disorders.

Post-chemotherapy dendritic cell vaccination boosts immune recovery and tumor targeting, helping extend survival in ovarian cancer patients.

A reverse thermo-reversible ocular hydrogel is applied as a liquid, gels at eye temperature, and treats dry eye without added actives.

Enzymatic treatment shifts onion concentrate toward high fructan content, reducing foaming, sticking, and browning while preserving flavor.

Surfactant-based liquid rifaximin keeps the drug dissolved, prevents crystallization, and enables lower, more accurate bowel-disorder dosing.

Selective Bcl-xL inhibitors based on diamino-pyridazinyl derivatives trigger tumor-cell apoptosis while aiming to limit harm to healthy cells.

Selective pyridine-based PI3K inhibitors address isoform similarity, lowering toxicity while sustaining tumor growth suppression.

Novel pyrimidine-based ACK1 inhibitor scaffolds improve pharmacokinetics while preserving potent kinase inhibition for cancer treatment.

A pressurized wound irrigator delivers chlorhexidine and lauroyl arginate directly to the site to cut microbial burden faster with lower allergy risk.

Novel ATK inhibitor compositions improve brain penetration and tolerability while reducing neurodegeneration and motor dysfunction in Parkinson's disease.

Specific HMOs including 3-SL, LNT, and core-HMOs are added to infant nutrition to extend night sleep and reduce awakenings without adverse effects.

Tricyclic derivative compounds improve PI3Kα selectivity without losing anti-tumor activity, helping reduce side effects from off-target PI3K inhibition.

A pumpkin and inulin prebiotic blend supports feline digestive health while avoiding the storage, handling, and palatability limits of probiotics.

An orally bioavailable B2-receptor antagonist prevents or treats angioedema while avoiding injection burden and injection-site reactions.

A synthetic H2CBD analogue preserves seizure control while avoiding THC conversion, contamination risks, and sleepiness.

Novel mPTP inhibitor compounds tune structure for brain penetration, low CYP2D6 inhibition, and improved oral exposure.

Combining a DYRK1A inhibitor with a GLP1R agonist drives specific human beta cell proliferation while limiting off-target effects in diabetes treatment.

Six X7 hydrochloride crystal forms are screened by XRPD and thermal analysis to identify a more stable solid form for storage and formulation.

Liquid THC microreservoirs in a polysiloxane adhesive patch sustain transdermal flux for up to 7 days despite rapid metabolism.

Small-molecule compounds stimulate RPE cell pigmentation and growth to regenerate damaged retinal tissue in AMD and geographic atrophy.

Staggered GI release of orlistat and acarbose improves weight and glucose control while reducing gastrointestinal side effects.

Selective pyrimidinone RIPK1 inhibitors address weak disease coverage of existing compounds by modulating cell death and inflammation pathways.

Pyrazoleamide derivatives inhibit MAT2A to exploit MTAP deletion, slowing cancer progression in genetically defined tumors.

Threo methylphenidate analogues reduce alpha-synuclein aggregation while preserving motor improvement and protecting nigrostriatal neurons.

By pairing indole-substituted quinolines with Plk1 inhibition, this case shows indirect c-MYC depletion and stronger tumor remission.

Crystal nucleus materials enable oral thin films to carry drug loads above saturation while preserving uniform crystallization, film strength, and bioavailability.

Remote loading into trapping-agent liposomes raises drug-to-lipid ratio and encapsulation efficiency while extending sedative release.

An angular imidazolinopyrimidinone induces TRAIL mRNA in macrophages to selectively trigger cancer cell apoptosis.

New KRas G12D inhibitor compounds adjust chemical structure to improve safety and efficacy in treating lung, colorectal, and pancreatic cancers.

Crystalline and amorphous macrocyclic ether forms enable TRK-sparing ROS1 and ALK inhibition with CNS safety and scalable API production.

Mutated WPRE and AAV-delivered GLA constructs sustain α-Gal A expression, reducing infusion burden and glycospingolipid buildup in Fabry disease.

Once-daily oral GnRH antagonist dosing suppresses testosterone without clinical flare and can be paused for faster recovery after surgery or illness.

A novel binder composition improves α-synuclein selectivity over existing probes, enabling more accurate optical and PET brain imaging.

Compounds of Formula (I) inhibit plasmepsin X and IX to block parasite egress and invasion, addressing malaria drug resistance.

Small-molecule CX3CR1 antagonists block fractalkine signaling to limit metastatic spread and support treatment of CNS and inflammatory disease.

Targets EGFR T790M resistance with a benzamide derivative that restores anticancer activity and shows synergy with cetuximab.

A heterocyclic RET inhibitor scaffold improves selectivity over VEGFR, reducing off-target toxicity while maintaining strong RET inhibition.

Targets intracellular nucleic acid sensors to boost IL-1, interferons, and TNF, strengthening neonatal and pediatric vaccine responses.

Quinazolinedione derivatives reduce ApoL1 G1/G2 cell toxicity to support treatment of ApoL1-associated kidney disease.

Chiral resolution isolates left-handed bicyclic morpholine salts that improve solubility, bioavailability, and liver protection over bicyclol.

Electropherogram feature analysis quantifies RNA disruption objectively, improving chemotherapy response prediction in treated samples.

By combining omega-3 phospholipids with other derivatives, these formulations improve bioavailability while reducing burping and reflux.

Specific excipient ratios enable stable 5-HT6 antagonist tablets with rapid disintegration and complete drug release within 30 minutes.

Targeted triazolopyrimidine substitutions improve PDE2 inhibition potency and selectivity while supporting neuroprotection and cognitive therapy.

A formula I antiviral compound lowers viral burden, suppresses replication, and helps control severe West Nile and influenza infections.

A licorice-derived polyphenol mixture stabilizes transthyretin tetramers to suppress monomerization, amyloid fibrils, and disease progression.

ETB receptor agonists combined with centhaquin improve renal blood perfusion after hemorrhagic shock to help prevent acute kidney injury.

Engineered anti-TIGIT antibodies block ligand binding and boost T cell and NK cell activation for cancer and infectious disease treatment.

Amorphous nilotinib fumarate or tartrate dispersions raise fasted-state bioavailability and reduce food-driven pharmacokinetic variability.

Fumarate and p-toluenesulfonate crystal forms improve RET inhibitor bioavailability, stability, and pharmaceutical manufacturability.

A halogenated alcohol solvent and guanidine route boosts aminopyrimidine yield and makes large-scale synthesis more practical.

Dual plasmepsin IX and X inhibition blocks parasite egress and invasion, offering a route to treat drug-resistant malaria.

A medicant strip placed next to the wound diffuses therapy directly to the site while the adhesive-cured mesh forms a protective microbial barrier.

Icaritin promotes platelet activation, shortens thromboplastin time, and helps prevent drug-induced bleeding complications.

A lip-and-gum nicotine tablet uses pH regulation and buccal absorption to relieve cravings quickly while reducing throat irritation.

Small-molecule RACK1 inhibitors block cancer cell migration and invasion by disrupting phosphorylation, focal adhesion anchoring, and vimentin expression.

Selective M4 antagonists improve antiparkinsonian activity while limiting peripheral adverse effects from non-selective muscarinic blockade.

Bridged MGL modulators raise endogenous 2-AG to treat pain, neuroinflammation, and mood disorders while limiting broad cannabinoid side effects.

Low-dose DC009 treats acute ischemic stroke while limiting bleeding risk and maintaining low plasma exposure with improved neurological outcomes.

Adding KCa3.1 agonists during TIL culture boosts expansion while preserving CD8+ and CCR7+ phenotypes for stronger cancer cell therapy.

Heteroaryl amide compounds improve LRRK2 inhibition selectivity, helping address Parkinson's disease with fewer off-target effects.

Selective breeding and doubled haploid production raise broccoli S-methylmethionine to 48 mg/100 g FW or more for food and pharmaceutical use.

Calcium-sensing receptor antagonistic heterocycles offer a new drug approach for heart failure and pulmonary hypertension with potential cardiac benefit.

Small molecule TRPC5 modulators use imidazodiazepinedione chemistry to treat kidney disease while reducing side effects and dependence risk.

ATP-non-competitive TNIK inhibitor pyrazoles improve selectivity and can synergize with irinotecan to target cancer stem cells.

A substituted bicyclic heteroaryl scaffold improves TLR7/8/9 inhibition with better stability, bioavailability, and lower toxicity.

Selective plasma kallikrein inhibitors improve treatment of retinal edema and hereditary angioedema while limiting off-target adverse events.

Combining an adenosine derivative with a capsid inhibitor targets reverse transcription and nuclear import to curb resistant HIV and support longer dosing.

Targeted anti-CD74 ADCs deliver Mcl-1 inhibitors into cancer cells to overcome resistance, induce apoptosis, and limit off-target toxicity.

Structurally modified aminoglycosides broaden activity against resistant Gram-negative and Gram-positive bacteria while reducing nephrotoxicity and ototoxicity.

PCR detection of DUX4-linked polymorphisms improves FSHD screening, while antisense inhibition targets the disease-driving DUX4 expression.

Selective BRD9 degrader compounds use proteasomal targeting to improve cancer efficacy while limiting off-target toxicity and hepatic clearance.

Macrocyclic compounds stabilize misfolded CFTR and improve membrane trafficking, helping restore ion balance and lung function in cystic fibrosis.

A cleavable siderophore-methotrexate conjugate uses bacterial iron uptake to boost antibacterial activity while reducing human-cell toxicity.

Small-molecule BTK inhibitors use optimized dosing to sustain target occupancy and improve treatment of B-cell malignancies.

A hydrate crystal form of fruquintinib replaces unstable anhydrates and organic solvates to improve stability, solubility, and hygroscopicity.

An anhydrous lipid-surfactant formulation improves oral absorption of poorly permeable CGRP inhibitors while limiting aggregation and GI degradation.

A PEgRNA-guided reverse transcriptase writes precise base changes and small indels without double-strand breaks or HDR.

Alternative-site EGFR inhibitors target T790M and C797S mutants to overcome TKI resistance while reducing wild-type EGFR toxicity.

Combining hepatitis B surface and core antigens with CpG and saponin adjuvants boosts humoral and cellular immunity to break immune tolerance.

Peptide-linked antibiotics use cleavable linkers and bacterial transporters to raise intracellular drug levels against resistant strains.

A cleavable codrug linker enables single-dose release of alpha2 adrenergic and muscarinic agonists to improve glaucoma and presbyopia treatment.

Blocking glucagon receptor signaling lowers blood glucose and ketones in severe insulin resistance while reducing reliance on high-dose insulin.

Surface-modified stem cell exosomes bind dopamine receptors or amino acid transporters to improve brain delivery and protect neurons.

A composite adhesive patch uses transcutol and compatible solvents to raise vitamin D skin permeation while limiting irritation and sensitization.

A mixed hop and citrus peel extract balances estrogenic activity, bone formation, and lipid control while reducing hormone-therapy side effects.

Pyridinone-containing PD-L1 inhibitors use modular heterocyclic substitution to improve immune response and address low clinical response rates.

Enzymatic depolymerization produces low-molecular-weight chondroitin sulfate with narrow distribution, higher bioavailability, and stronger chondrocyte repair.

A glucocorticoid receptor antagonist reveals ACTH and cortisol response patterns to distinguish ACTH-dependent from ACTH-independent Cushing's syndrome.

A combined fungal mycelium fraction balances pro- and anti-inflammatory cytokines to ease cytokine storms without broad immune suppression.

Liposomal trans-crocetin improves solubility, stability, and half-life to sustain oxygen delivery in hypoxia, ARDS, sepsis, and ischemia.

Amorphous polymer dispersions help substituted pyrazolopyrimidines resist recrystallization and improve oral bioavailability at physiological pH.

Multiple salt and polymorphic forms of Compound A improve stability, solubility, and bioavailability while preserving Aurora kinase and FLT3 inhibition.

Novel small-molecule PD-1/PD-L1 inhibitors block immune checkpoint signaling to enhance T cell response with more selective cancer treatment.

Modified pyrimidine oligonucleotides suppress non-Watson-Crick pairing, reducing off-target binding while improving nuclease resistance.

Structural changes to imidazopyridines improve glucosylceramide synthase inhibition, half-life, bioavailability, and selectivity.

A pH 6-7 oral aqueous formulation uses eucalyptus oil and alkalizing agents to improve flurbiprofen solubility, taste, and mucosal absorption.

Drug-induced shedding of prostatic cells into urine or semen improves noninvasive prostate cancer and BPH detection while reducing biopsy burden.

MLIP-AS1 copy number testing predicts whether ocular hypertension patients respond better to prostaglandins or β-blockers.

Combining KRAS G12C inhibitors with FAK, MEK, or dual RAF/MEK inhibitors improves antitumor response while limiting high-dose toxicity.

Novel entrectinib crystal forms improve solubility, stability, and powder flow while avoiding static buildup in large-scale formulation.

Wet-granulated melatonin with sodium alginate and calcium lactate balances fast sleep onset with sustained overnight release.

By recruiting BTK to an E3 ligase for degradation, these intermediates help address C481 mutation resistance in BTK-driven cancers and autoimmune disease.

A low-endotoxin sodium alginate composition fills meniscus defects in avascular areas to regenerate fibrocartilage and restore strength.

Loaded exosomes deliver STING agonists to brain tumors or meningitis sites, boosting immune signaling where standard therapies fall short.

A pyrazole derivative composition suppresses reactive oxygen species and fibrosis markers to treat pulmonary fibrosis with fewer side effects.

A high-affinity Fab fragment binds ticagrelor to rapidly restore platelet aggregation and reduce bleeding risk before surgery.

Pairing a duocarmycin-bearing ADC with an ATR inhibitor boosts tumor cell killing while helping address toxicity limits of single-agent therapy.

By pairing a c-KIT inhibitor with MEK, ERK, or RAF blockade, this case shows how resistant GIST cells can be driven toward apoptosis and delayed regrowth.

Sulfonimidamide compounds inhibit NLRP3 inflammasome activation while improving pharmacological properties for treating IL-1β and IL-18 driven disorders.

Defined crystalline forms of Compound 49a improve stability, shelf life, and dissolution while supporting consistent multi-kilo pharmaceutical production.

DNA aptamers targeting CD40 replace costly, immunogenic antibodies to boost vaccine immune responses with lower immunogenicity.

A tannin-zinc oral formulation extends active residence in the mouth and pharynx to help block viral and bacterial acquisition.

Spray-dried powder with polymer stabilizes a TRPC5 inhibitor for solid dosage, improving solubility, flowability, and capsule filling.

Two adjacent monodisperse PEG side chains mask hydrophobic drugs, reduce ADC aggregation, and enable sustained intracellular release.

Lymph-targeted celecoxib lipid prodrugs reverse mesenteric lymphatic dysfunction to improve insulin resistance, glucose tolerance, and weight control.

Controlled hydroxypropyl beta-cyclodextrin purification removes endotoxin and other impurities for safer chronic intrathecal dosing.

Topical JAK/STAT inhibitors with penetration enhancers strengthen brittle nails while limiting side effects, including in pediatric use.

Specific amino acids with electrolytes help protect lung function and treat radiation-induced pneumonitis and fibrosis after therapy.

Sphingomyelin-cholesterol liposomes carry GM1 across the blood-brain barrier with simpler formulation, lower side effects, and brain delivery.

Novel quinoline and quinazoline CYP4A inhibitors improve insulin sensitivity while reducing oxidative stress, inflammation, and hypoglycemia risk.

Psilocybin treatment for fibromyalgia pairs contraindication screening and integration sessions to improve pain, sleep, and mood with minimal side effects.

Controlled oral minoxidil release stabilizes serum levels to support hair regrowth while reducing peak-related adverse effects.

A ready-to-use subcutaneous iron octasaccharide complex helps replenish iron stores in companion animals while limiting side effects.

By recruiting E3 ubiquitin ligase to MK2, these degrader compounds enable proteasomal removal to reduce inflammation-linked kinase activity.

Polymeric micelles solubilize TAK-441 for epidermal targeting in resistant basal cell carcinoma while limiting transdermal permeation.

Specific cationic lipid ratios enable lung-targeted nucleic acid delivery without biomolecular targeting, improving expression while reducing systemic toxicity.

Targeted neurosteroid substituent changes improve metabolic stability and bioavailability, enabling non-intravenous CNS treatment.

Methotrexate co-administration helps pegloticase lower uric acid with fewer infusion reactions and longer response in chronic refractory gout.

AI-designed liver NAREs boost tissue-specific gene expression while shrinking cassette size to lower vector dose and immune response.

Phenothiazine derivatives modify the Ferrostatin-1 scaffold to preserve ferroptosis inhibition while improving solubility and lowering cytotoxicity.

Structured lipid amines tune nanoparticle composition to protect nucleic acids and proteins while improving cellular uptake, safety, and specificity.

Galactosylated macrolides selectively eliminate senescent cells and inhibit cancer stem cells by modulating mitochondrial metabolism.

Controlled oral minoxidil release lowers peak serum exposure while maintaining sustained drug levels for hair-loss treatment with fewer adverse effects.

Folded 3D ruthenium complexes improve galectin-1 selectivity by filling the binding cavity and adding electrostatic and π-π interactions.

A small molecule inhibitor blocks Fbxo7-Pink1 binding to raise Pink1 levels, reduce mitochondrial injury, and curb inflammation.

Controlled oral minoxidil release maintains therapeutic serum levels longer while lowering peak-related adverse effects in hair loss treatment.

A low-volume intranasal naloxone formulation enables rapid absorption, avoids needles, and supports overdose treatment by untrained users.

Complementary RNA oligonucleotides silence MAPT mRNA to target tau pathways and address inadequate disease-modifying therapy.

Liposomal mitoxantrone treats recurrent NMOSD while reducing cardiotoxicity through controlled delivery and lower-dose periodic dosing.

A purified synthetic copy of formula (A) improves quality stability and scalability while promoting energy use and suppressing body fat.

Novel compounds modulate MALT-1 proteolytic activity to address the lack of effective treatments for autoimmune, inflammatory, and cancer disorders.

Synthetic CBD is stabilized in an oral liquid using solvents, oils, surfactants, and buffers to avoid impurities and antioxidant-related risks.

Stealth LNPs use scFv or VHH targeting moieties to extend circulation and deliver nucleic acids more specifically to immune effector cells.

Serum biomarker screening helps identify rheumatoid arthritis patients more likely to benefit from anti-IL-6R antibody treatment.

Protective compounds stabilize vascular endothelium and the blood-brain barrier to limit hemorrhage and edema during thrombolytic or anticoagulant therapy.

Targeting PKR or eIF2α phosphorylation suppresses toxic RAN protein buildup while preserving normal protein synthesis pathways.

Nanofiber-coated nanoparticles improve mucus penetration, cell uptake, and lower respiratory tract retention while reducing systemic side effects.

Chemical structure changes in hemoglobin modulators improve pharmacokinetics while preserving HbS polymerization inhibition and oxygen affinity.

Structural changes in ionizable lipids improve nucleic acid encapsulation and delivery while reducing toxicity in lipid nanoparticles.

A parathyroid hormone, osteoclast inhibitor, and bone void filler composition promotes fracture union while reducing repeat surgery.

A polymer-based solid dispersion converts an EED inhibitor to an amorphous form, improving dissolution, fluidity, and oral bioavailability.

Esterase-treated decaffeinated green coffee extract lowers postprandial insulin while improving insulin sensitivity and muscle glucose uptake.

Combining GH, DHEA, and metformin supports thymus regeneration while limiting GH-related hyperinsulinemia, insulin resistance, and cancer risk.

Oral ASBT inhibitor dosing lowers serum bile acids in cholestasis while improving pruritus, growth, and long-term symptom control.

Boosting 2-AG tone while reducing prostaglandin activity offers a targeted way to relieve migraine pain with fewer tolerability limits.

Localized anti-fibrotic compounds in modified implant polymers reduce fibrosis and preserve therapeutic device function.

Engineered GPC2-binding CAR T cells target neuroblastoma with selective cytotoxicity, addressing poor prognosis driven by invasion and metastasis.

Antisense oligonucleotides bind transthyretin mRNA to lower TTR protein levels and address amyloidosis without invasive liver transplantation.

Targeting endometriosis pain with a diaminopyrimidine compound offers relief while avoiding the hormonal side effects and recurrence limits of current therapies.

Fine particles under 10 μm keep low-solubility actives stably suspended above saturation, preventing large crystals during freeze-thaw cycling.

Using eflornithine to cross the blood-brain barrier and target grade 3 astrocytoma improves survival where recurrent nonsurgical options are lacking.

Amido-substituted heterocycles inhibit herpesvirus polymerase to curb replication, broaden antiviral coverage, and reduce toxicity risk.

Tyrosine acts as a sacrificial nitration target to preserve protein function, restore glutamine balance, and lower ammonia in nitration-linked disease.

Dantrolene blocks calcium release pathways to suppress SARS-CoV-2 replication, lower viral load, and improve COVID-19 symptoms.

Taladegib inhibits Gli1 to curb pulmonary fibrosis progression and improve lung function with better tolerability than earlier SMO inhibitors.

Moderate zinc binders and alkyl glycoside replace EDTA to speed insulin onset while preserving physical and chemical stability.

A new azacyclic compound class activates TRPM8 channels to deliver longer-lasting cooling on skin and mucosa at very low concentrations.

A dihydrotanshinone I derivative offers a non-surgical CCM treatment approach by reducing lesion burden and protecting vascular integrity.

A two-phase non-aqueous nail treatment builds antifungal levels early, then cuts dosing frequency to limit hydration and discoloration.

Halogenated nucleoside compositions improve bioavailability and target RNA polymerase across coronaviruses and vector-borne viral infections.

C1-C3 alkyloxymethyl side chains help lipid nanoparticle lipids keep stealth behavior while reducing anti-PEO antibodies and improving storage stability.

Polymerized cannabinoid chains improve aqueous delivery and thermal stability, enabling sustained release in coatings, fibers, and patches.

Powered jet injectors deliver testosterone with less pain, minimal leak-back, and steadier plasma levels than injections or creams.

Modified antisense polynucleotides bind PD-L1 mRNA to suppress protein expression and support treatment of cancers and chronic infections.

Biological response modifiers condition immune cells for in vivo CAR-T engineering without lymphodepletion, improving effector expansion and Treg suppression.

miR-155-rich stem cell microparticles activate NK cells by regulating SHIP1 and boosting granzyme B for stronger immune response.

Targeting the SHP2 N-SH2 domain with bicyclic compounds enables allosteric inhibition where effective small-molecule options have been limited.

Novel pyrazolo[3,4-b]pyrazine derivatives improve selective SHP2 inhibition to block cancer signaling while aiming to limit side effects.

Antioxidant-stabilized levodopa and carbidopa formulations cut hydrazine degradation and support steadier dopaminergic therapy.

A five-step mild synthesis route cuts reflux time, simplifies PI3K inhibitor preparation, and supports easier scale-up and process control.

A cross-linking skin film improves adhesion and wear time while masking deep wrinkles and scars without invasive cosmetic procedures.

Gas phase atomic layer deposition creates uniform inorganic shells that prevent premature nanoparticle dissolution while enabling controlled drug release.

Oral exosomes and engineered bacteria deliver antiviral factors in the gut to curb herpesvirus-driven inflammation, dysbiosis, and barrier injury.

Modified CHO cells enable commercial-scale recombinant lubricin production while preserving human-like glycosylation needed for boundary lubrication.

Prazole compounds offer a non-invasive way to inhibit aortic valve calcification and help preserve valve function without valve replacement.

A multi-fused ring small molecule targets the GLP-1 receptor to enable oral diabetes and obesity treatment without injections.

Controlled crushing of segmented emulsion cartridges enables precise microneedle skin delivery with optional IR or ultrasonic absorption support.

Hydroxylated vitamin D3 feed supplements lower somatic cell count in dairy cows while improving milk quality and supporting milk yield.

A crystalline CFTR modulator form improves CFTR function and stability in F508del-related cystic fibrosis and supports combination therapy.

Halo-substituted heterocyclyl compounds stabilize mutant p53, restore DNA binding, and reactivate apoptosis in p53-mutant cancers.

A fixed-dose abiraterone acetate and niraparib tablet cuts pill burden while maintaining uniform delivery and bioavailability in mCRPC treatment.

High-load AG10 tablets use microcrystalline cellulose and selected excipients to prevent erosion while preserving stable, rapid dissolution.

Dimeric compounds selectively inhibit GYS1 to lower tissue glycogen while limiting off-target effects in glycogen storage diseases and cancer.

Controlled oral minoxidil release sustains serum levels for hair loss treatment while lowering peak-related adverse effects.

Block copolymer and charged polymer particles improve biologic delivery stability and blood residency while limiting cytotoxicity and immune response.

Detecting SWI/SNF complex suppression helps identify tumors likely to respond to GPX4 inhibitors, enabling more selective cancer treatment.

Small-molecule KIF18A inhibitors block ATPase and microtubule activity to trigger mitotic arrest and apoptosis in cancer cells.

Aseptic pH-buffered azithromycin premix avoids terminal sterilization, enabling stable ready-to-use IV infusion with fewer errors.

A foaming carbohydrate-acid-carbonate powder masks drug bitterness while maintaining aqueous dispersibility and dissolution.

Echocardiogram-guided aficamten dosing lowers left ventricular outflow tract pressure gradients in obstructive HCM while preserving heart filling.

Sub-micromolar Pf blood-stage inhibitors are tuned for aqueous solubility at pH 7.4, supporting oral malaria treatment against resistant strains.

A breakable-seal multi-chamber bag stores lyophilized drug and diluent separately, enabling in-bag mixing that cuts handling time and exposure risk.

A cellulose-alginate saccharide matrix delivers pH-independent 24-hour release to stabilize overnight blood glucose and limit nocturnal hypoglycemia.

Removing propylene glycol, endotoxin, and unsubstituted beta-cyclodextrin enables safer chronic intrathecal dosing for Niemann-Pick Type C.

Bicyclic 1,4-diazepanones target the troponin complex to modulate skeletal sarcomere contractility for neuromuscular disorders.

A single-phase hydroalcoholic diclofenac gel removes oily residue and haze while maintaining permeation and crystallization control.

Optimized reaction steps and controlled crystallization raise maribavir yield while limiting impurities and securing the Form VI polymorph.

Alumina chromatography and solvent precipitation define hydroxypropyl beta-cyclodextrin composition and remove impurities for chronic intrathecal use.

Nitrogen-substituted pyridazinopyridone derivatives inhibit SOS1 and can boost KRAS G12C inhibitor efficacy for cancer treatment.

Adding alpha 1,3 and alpha 1,4 fucosylated oligosaccharides to infant formula helps delay adiposity rebound and lower later obesity risk.

Discrete printable volume increments enable flexible drug distribution, controlled release profiles, and targeted pharmaceutical dosage forms.

Atrium-selective TASK-1 inhibition treats atrial arrhythmias while minimizing brain penetration and central nervous system side effects.

Selective CFB modulation lowers CFB mRNA and protein to curb harmful complement activation while reducing tissue damage in kidney and ocular disease.

Biomarker-guided IL-17 antagonist dosing targets high-risk rheumatoid arthritis patients to improve response and reduce adverse effects.

Nucleic acid aptamers selected and truncated for ICAM-1 binding help block rhinovirus entry while reducing sequence complexity.

Novel benzoxazole derivatives inhibit IL-6, IL-1β, and TNF-α to improve small-molecule treatment options for inflammatory diseases.

Activated ILC2 cells in the choroid plexus use cytokines such as IL-33 to reduce neuroinflammation and improve aging-related cognition.

Multi-target pyrimidine compounds inhibit FLT3, VEGFR, and SYK to address mutation-driven resistance in AML and related cancers.

Red-flesh peach extract combines antioxidant skin protection against blue light injury with higher heme and blood iron content.

A two-phase elagolix dosing regimen balances symptom control with reduced bone mineral density loss to support longer treatment use.

Bifunctional compounds recruit BCL-XL and BCL-2 to E3 ligases, overcoming protein stabilization through targeted degradation for cancer therapy.

Local chemotherapeutic release from an anchored esophageal implant helps limit stent migration, suppress tumor growth, and maintain lumen patency.

Riluzole prodrugs shield against first-pass liver metabolism and plasma-cleave after oral dosing to deliver more predictable exposure.

Defined anhydrous and hydrated BET inhibitor crystal forms improve preparation reproducibility, purification, stability, and bioavailability.

Nanoparticle-encapsulated GSK-3 inhibitors enhance Wnt signaling in APC-mutant tumors to curb cancer growth while limiting toxicity.

Targeting LPXC with aromatic acetylene derivatives suppresses lipoid A biosynthesis and expands options for multidrug-resistant Gram-negative infections.

A carboxylic acid-directed 1,4-dihydropyridine reduction boosts trans GPCR modulator purity and avoids inefficient cis-containing mixtures.

Annulated pyridine compounds selectively inhibit CYP11B1, CYP11B2, CYP7A1, and CYP8B1 to lower excess steroid hormones across multiple diseases.

A CB1-modulating compound reduces body sway, loss of alertness, and feeling high during acute cannabinoid intoxication.

Oral odevixibat blocks ileal bile acid reabsorption to lower serum bile acids and pruritus in PFIC without surgical intervention.

Aptamers protect VWF multimers from VAD shear damage, reducing bleeding and thrombus formation while preserving vessel patency.

An oral nonpeptide GnRH antagonist combined with estrogens and progestogens reduces heavy menstrual bleeding while avoiding injection burden.

Selective SMS2 inhibition with alkoxybenzo heterocyclic amines improves activity, stability, and solubility for metabolic and inflammatory disease treatment.

Brain-penetrant oxadiazole compounds selectively inhibit HDAC6 to treat neurodegeneration while limiting side effects from pan-HDAC activity.

Controlled crystallization yields stable anhydrous forms that prevent polymorphic change and preserve consistent JAK inhibitor bioavailability.

Novel bicyclic LXR modulators tune lipid metabolism while improving stability and solubility to treat dyslipidemia without liver steatosis.

IRAK4-targeted substituted indazoles help control allergic and inflammatory disease in animals while reducing side effects seen with current treatments.

A solid adagrasib tablet with selected excipients improves bioavailability and shelf-life stability while reducing nausea, vomiting, and diarrhea.

A PC-PE-PS phospholipid adjuvant matures immunosuppressive TADCs, boosts cytokine production, and suppresses tumor growth.

Carrier protein nanoparticles target PD-L1 or PD-L2 to improve tumor uptake and boost PD-1 immunotherapy without unstable ADC linkers.

A sesame oil and propylene glycol monolaurate oral formulation helps native testosterone resist first-pass loss, improving bioavailability with fewer side effects.

An alkaline epinephrine composition uses pH control, antioxidants, and metal chelators to limit degradants and extend shelf life.

Nonpareil bead and polymer coatings target rifaximin release to specific GI regions, improving local dissolution while limiting systemic exposure.

A layered core-SR-DR formulation delays methylphenidate release, then sustains drug levels to support once-daily ADHD treatment.

Novel cationic lipids enable serum-compatible nucleic acid delivery with higher transfection, lower material use, and reduced toxicity.

Isoquinolone PI3K inhibitors use ring substituent changes to target mutant PI3Kα while reducing toxicity in healthy cells.

High-dose niacin suppresses ROS and collagen buildup in hepatic stellate cells, supporting regression of liver fibrosis and cirrhosis.

A sugar-sphere huperzine coating with ethyl cellulose slows plasma peaks, reducing nausea and enabling twice-daily high-dose treatment.

Selective end-group termination in poly(2-oxazoline) expands functionalization while preserving biocompatibility and stealth for drug and gene delivery.

Defined phosphorothioate stereochemistry in CpG oligonucleotides improves TLR9 agonist or antagonist consistency, stability, and delivery.

Polyunsaturated fatty acid monoglycerides combined with cannabinoids selectively inhibit COX-2, boosting efficacy while lowering cardiac risk.

Continuous subcutaneous cannabinoid infusion improves bioavailability, avoids first-pass liver toxicity, and supports lower dosing.

New crystal forms II and III cut moisture uptake and improve storage stability of a JAK-related heterocyclic drug compound.

Engineered iPSC-derived platelets carry protein, nucleic acid, or drug cargo to target sites while reducing donor dependence and immune reactions.

Selective CDK2 and CCNE degradation via the ubiquitin-proteasome pathway helps counter resistance linked to cyclin E overexpression.

Sustained-release tacrolimus nanoliposomes enable subconjunctival delivery for anterior eye disease while reducing frequent eye drops and injection risk.

Engineered extracellular vesicles use cleavable cell-penetrating linkers to raise payload capacity, target tissue selectively, and limit systemic toxicity.

Surface-charged exosomes use cationic peptides and proteins to penetrate cartilage, improve joint retention, and deliver mRNA to chondrocytes.

Low-dose platinum chemotherapy releases tumor neoantigens, while CpG and R848 boost T-cell immunity to inhibit growth with fewer side effects.

Selective TYK2 modulators with high intestine-to-plasma exposure aim to improve IBD remission while limiting adverse effects and off-target activity.

Pneumatic powder and plasticizer delivery in a fluidized bed enables uniform dry coating of tablets, capsules, and granules with less agglomeration.

Ru or Rh chiral hydrogenation raises RAF inhibitor enantiomeric excess to at least 90% ee, supporting BRAF-mutant cancer treatment.

TCF4 inhibition targets mesenchymal-like cancer cells to restore immune checkpoint therapy response by improving antigen presentation.

Acid-labile zwitterionic polymers switch from cationic to neutral in endosomes, improving RNA release and transfection from lipid nanoparticles.

A modular synthesis route for Compound 1 supports selective INaL modulation to address electrical and contractile dysfunction.

Species-matched anti-NGF antibodies block NGF-TrkA pain signaling to provide prolonged OA pain relief in dogs and cats with lower immunogenicity.

Targeted AC9 silencing with siRNA raises LDL receptor expression and lowers blood LDL to address cardiovascular risk from excess LDL.

Substituted imidazopyridine compounds target fibrosis by reducing fibrotic damage and lung injury, including Covid-19-related cases.

Age-based lomitapide dosing helps pediatric HoFH patients lower LDL-C and related lipids while managing unknown safety and tolerability.

Novel polycyclic sulfonamides improve GFRα1-RET activity, solubility, permeability, and pharmacokinetics for neurological disorder treatment.

A stable, non-toxic oral pilocarpine liquid uses patient-friendly excipients to improve ingestion, taste, and room-temperature shelf life.

pH-buffered aqueous psilocybin formulations balance rapid therapeutic onset with shelf-life and lower injection site reactions.

Controlled crystallization of R-oxybutynin HCl polymorphs improves stability, batch consistency, and therapeutic efficacy for OSA treatment.

Stable gepotidacin mesylate crystal forms control hydrate and solvate instability, enabling reliable antibacterial pharmaceutical compositions.

Compounds of formula (I) uncouple active RAS from effectors to block KRAS, HRAS, and NRAS signaling while reducing resistance and toxicity.

New bicyclic heterocyclic IRAK4 inhibitors improve stability, bioavailability, and toxicity balance while maintaining therapeutic activity.

An oil-based nimodipine emulsion uses lecithin and glycerol to avoid ethanol, Tween 80, and crystallization while improving stability and tolerability.

Novel benzothiophene carboxylate TRPM3 antagonists improve potency and pharmacokinetics while aiming to lower side effects in pain and epilepsy.

Structural tuning of a bicyclic PARP-1 inhibitor improves selectivity while reducing intestinal and hematological toxicity.